Injecting drug use as risk factor for visceral leishmaniasis in AIDS patients

被引：22
|
作者：
Amela, C
LopezGay, D
Alberdi, JC
Castilla, J
机构：
[1] National Centre for Epidemiology, 'Carlos III' Institute of Health, Madrid
[2] Servicio de Epidemiología, Consejería de Salud, Madrid
[3] Centro Nacional de Epidemiología, E-28029 Madrid, c/ Sinesio Delgado
来源：
EUROPEAN JOURNAL OF EPIDEMIOLOGY | 1996年 / 12卷 / 01期
关键词：
AIDS; injecting drug use; leishmaniasis;
D O I：
10.1007/BF00144435
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
In Madrid Region 6652 AIDS cases were diagnosed between 1982 and 1993. Visceral leishmaniasis (VL) was present in 166 (2.49%). VL frequency among injecting drug users proved higher than that for the other transmission categories (relative risk 2.57; 95% confidence interval 1.64-4.01). This could point to an alternative Leishmania transmission route via needle sharing.
引用
收藏
页码：91 / 92
页数：2
相关论文
共 50 条
  • [31] The Use of Propofol as an Anaesthetic Agent in Dogs with Visceral Leishmaniasis
    Kilic, Nuh
    Pasa, Serdar
    JOURNAL OF ANIMAL AND VETERINARY ADVANCES, 2008, 7 (10): : 1310 - 1315
  • [32] Changing profiles of injecting drug users with AIDS in a Hispanic population
    Amill, A
    Gómez, MD
    Fernández, DM
    Bangdiwala, SI
    Ríos, E
    Hunter, RF
    ADDICTION, 2004, 99 (09) : 1147 - 1156
  • [33] Intestinal leishmaniasis in patients with AIDS.
    GarciaSamaniego, J
    Laguna, F
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 1997, 89 (02) : 145 - 145
  • [34] Antineoplastic drug, carboplatin, protects mice against visceral leishmaniasis
    Tejinder Kaur
    Prerna Makkar
    Kulbir Randhawa
    Sukhbir Kaur
    Parasitology Research, 2013, 112 : 91 - 100
  • [35] HIV/AIDS-associated visceral leishmaniasis in patients from an endemic area in central-west Brazil
    Alexandrino-de-Oliveira, Priscilla
    Santos-Oliveira, Joanna Reis
    Cavalheiros Dorval, Maria Elizabeth
    Brandao Da-Costa, Francisco das Chagas
    Oliveira Leite Pereira, Gracy Regina
    da Cunha, Rivaldo Venancio
    Miranda Paniago, Anamaria Mello
    Da-Cruz, Alda Maria
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2010, 105 (05): : 692 - 697
  • [36] Long-term monitoring of visceral leishmaniasis in patients with AIDS - Relapse risk factors, value of polymerase chain reaction, and potential impact on secondary prophylaxis
    Bourgeois, Nathalie
    Lachaud, Laurence
    Reynes, Jacques
    Rouanet, Isabelle
    Mahamat, Aba
    Bastien, Patrick
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 48 (01) : 13 - 19
  • [37] A Rare Case of Visceral Leishmaniasis Diagnosed by Endoscopy in an Anemic Patient With HIV/AIDS
    Dawkins, Makeda
    Lin, Zilan
    Cohen, Cynthia
    Mikkilineni, Soumya
    Shakil, Fouzia
    Tewari, Virendra
    ACG CASE REPORTS JOURNAL, 2023, 10 (07)
  • [38] The emergence of concurrent HIV-1/AIDS and visceral leishmaniasis in Northeast Brazil
    Nascimento, E. T.
    Moura, M. L. N.
    Queiroz, J. W.
    Barroso, A. W.
    Araujo, A. F.
    Rego, E. F.
    Wilson, M. E.
    Pearson, R. D.
    Jeronimo, S. M.
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2011, 105 (05) : 298 - 300
  • [39] Monitoring of Intracellular Nitric Oxide in Leishmaniasis: Its Applicability in Patients with Visceral Leishmaniasis
    Sarkar, Avijit
    Saha, Piu
    Mandal, Goutam
    Mukhopadhyay, Debanjan
    Roy, Susmita
    Singh, Sunny Kumar
    Das, Sukhen
    Goswami, R. P.
    Saha, Bibhuti
    Kumar, Deepak
    Das, Padma
    Chatterjee, Mitali
    CYTOMETRY PART A, 2011, 79A (01) : 35 - 45
  • [40] The epidemics of injecting drug use and HIV in Asia
    Ghys, PD
    Bazant, W
    Monteiro, MG
    Calvani, S
    Lazzari, S
    AIDS, 2001, 15 : S91 - S99
12345